Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Unlike earlier agents such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP and GLP-1 receptor agonist), retatrutide simultaneously activates three distinct hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Regular monitoring of HOMA-IR, fasting insulin, adiponectin, HbA1c, and hormone panels is essential to ensure optimal outcomes
When adverse effects occur, they are typically mild and may include: Nausea or stomach upset Diarrhea or loose stools (particularly at higher doses) Dizziness Headache Fatigue These effects are usually dose-dependent and resolve with dosage adjustment
Once opened (punctured with a needle), most compounded formulations remain viable for 28 days when refrigerated
US$ 21.48
US$ 29.87
US$ 26.93
US$ 25.18
US$ 25.86
US$ 23.05
US$ 22.03
US$ 21.93
